EPHA2 and neoplasm: Specifically, EphA2 overexpression is found in breast, ovarian, prostate, and pancreatic cancers and is correlated with aggressive tumors, high rates of tumor recurrence, and poor patient prognosis (8, 9, 10, 11, 12, 13, 14).